In 2000, Millennium Pharmaceuticals was the poster child for successful genomic companies. The rapid growth of the millennium and exuberant scores were associated with an elegant forged alliances with leading pharmaceutical, biotechnology and agriculture. However, as the market has changed, and the millennium had to be fully integrated, the type and structure of its unions have not worked. "Hide
by Alicia Loffler, Marcus Solf, Edward J. Zajac Source: Kellogg School Management 20 pages. Publication Date: January 1, 2004. Prod. #: KEL068-PDF-ENG
Related Case Solutions & Analyses:
Managing Proprietary and Shared Platforms
Stumbling Giant: R. J. Reynolds in the 1980s
Managing Change By Design
3M ESPE AG: Managing Intellectual Property in the Dental Impression Materials Market
Myriad (B): Breast Cancer Testing in Britain
Drilling South: Petrobras Evaluates Pecom
Renault-Volvo Strategic Alliance A: March 1993
Nike Inc. in the 1990s (B): Strategy and Management Changes–1993-94
Managerial Networks
Digital Equipment Corp.: The Endpoint Model (B2)
